Loading
Dose banding means your calculated dose is rounded to the nearest of a set of standard doses, so the pharmacy can make doses in advance. The difference from your exact dose is kept small, and studies show it gives about the same amount of drug in your blood as an individually calculated dose.
In dose banding the individually calculated dose (by body surface area, weight or AUC) is rounded to a predefined standard dose for a range of calculated doses, so that doses can be prepared in advance, waiting times cut, waste reduced and products quality-controlled before use. BOPA (2025) asks that adult anticancer doses be banded where bands exist, to the NHS England (England, Wales and Northern Ireland) or SOPPG (Scotland) national tables, and notes banding is not usually used in children; for carboplatin, a changed creatinine or weight leads to a new calculated dose, from which the new band is chosen, never a percentage change from the old banded dose.
The pharmacokinetic case comes from Chatelut (2012): using clearance data from 1,012 adults and six drugs, banding into three BSA bands changed individual doses by minus 14% to plus 22% but gave a spread of drug exposure very similar to BSA dosing, with no significant loss of precision except for paclitaxel (32.0% against 30.7%), while flat dosing was less precise for four of the six drugs. A hospital that allowed a maximum deviation of 10% found more prepared doses could be reissued and less waste for all agents studied except carboplatin. The NHS England tables and principles, which set UK limits, could not be read.
Why: Standard doses can be prepared ahead and checked in advance, shortening waits without losing accuracy.
“Note: SACT for adult patients should be dose banded where bands are available.”
Why: Children's doses and volumes must match their age and size more closely.
“Dose banding not usually used in children.”
Why: Comparing against an already rounded dose can hide or exaggerate a real change.
“Warning: it is NOT appropriate to use the previous banded dose to work out a percentage dose change threshold as this risks under or overestimating the actual carboplatin dose when banding.”
Why: Within sensible bands, the difference in drug levels between people is about the same as with exact body-size dosing.
“For the studied drugs, implementation of dose banding should be considered as it entails no significant increase in interindividual plasma exposure.”
How care is usually carried out, read from the guidelines and standards cited. Your own team's protocol and their judgement come first; this page is for understanding it, not for doing it yourself.
Band adult doses to national tables where they exist, starting from an individually calculated dose, and not usually in children (BOPA 2025); recalculate from new values rather than from the old band. The pharmacokinetic basis is Chatelut 2012 (no significant loss of precision against BSA dosing for five of six drugs). The UK national tables and their deviation limits could not be read, so no limit is stated; one hospital used a maximum deviation of 10%.
British Oncology Pharmacy Association 2025 · British Journal of Cancer (Chatelut et al.) 2012 · ESMO Open (Samani et al.) 2022
Where it differs: A hospital sets its own bands for paclitaxel, carboplatin, docetaxel, gemcitabine, irinotecan and oxaliplatin, allowing up to 10% deviation from the prescribed dose, built into electronic prescribing.
Evidence: In one hospital, reissuing of prepared doses rose for all agents except carboplatin (oxaliplatin from 3.7% to 27.8%) and waste fell, saving about 5,200 euros a year (van Huet 2025).
Journal of Oncology Pharmacy Practice (van Huet et al.) 2025
Shares Body surface area and weight-based dose calculation for anticancer drugs, including full doses in obesity, Body-surface-area dosing, Anticancer treatment prescribing and pharmacy verification before each cycle.
Shares Carboplatin dose calculation by the Calvert formula and kidney function, Anticancer treatment prescribing and pharmacy verification before each cycle, Carboplatin.
Shares Carboplatin dose calculation by the Calvert formula and kidney function, Body-surface-area dosing, Anticancer treatment prescribing and pharmacy verification before each cycle, Carboplatin.
Shares Carboplatin dose calculation by the Calvert formula and kidney function, Carboplatin.
Shares Anticancer treatment prescribing and pharmacy verification before each cycle, Paclitaxel / nab-paclitaxel, Carboplatin.
Shares Body-surface-area dosing, Carboplatin.
Shares Body surface area and weight-based dose calculation for anticancer drugs, including full doses in obesity, Carboplatin dose calculation by the Calvert formula and kidney function.